Download PDF
Thromb Haemost 1981; 46(02): 547-549
DOI: 10.1055/s-0038-1653407
Original Article
Schattauer GmbH Stuttgart

Platelet Hypersensitivity in Acute Malaria (Plasmodium falciparum) Infection in Man

E M Essien
The Department of Haematology, University of Ibadan, Ibadan, Nigeria
,
M I Ebhota
The Department of Haematology, University of Ibadan, Ibadan, Nigeria
› Author Affiliations
Further Information

Publication History

Received 19 March 1981

Accepted 29 June 1981

Publication Date:
05 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

During acute malaria infection, platelets in human platelet-rich plasma are hypersensitive to the addition of ADP between 1.0 uM and 5.0 uM, or adrenaline 0.11 uM as aggregating agents. The mean maximum aggregation amplitude (as % of light transmission) obtained from 8 subjects in response to added ADP (1.0 uM), 39.8 ± 27 (1SD), was significantly greater than the value in 6 controls (5.2±6.7 (1SD); t = 3, 51 P <0.005). A similar pattern of response was obtained with higher ADP concentrations (2.4,4.5 or 5.0 uM) in 22 patients and 20 control subjects (89.9±14.9% vs 77.8±16.5% (1SD) t = 2.45, P <0.02). Addition of 4.5 uM ADP to patient PRP usually evoked only a single aggregation wave (fused primary and secondary waves) while the typical primary and secondary wave pattern was usually obtained from controls.

Mean plasma B-thromboglobulin (BTG) concentration in 7 patients (208.3 ± 15.6 ng/ml) was significantly higher than the value in 6 control subjects (59.2±15.7 ng/ml; t = 13.44, P <0.002).

Keywords

Platelet hypersensitivity - Acute malaria infection
 

  • References

  • 1 Knuettgen H. Knochenmarkbefunde bei Malaria tertiana. Tropenmed Parasit 1949; 1: 178-194
    PubMedGoogle Scholar
  • 2 Hill GJ, Knight V, Jeffery GM. Thrombocytopaenia in vivax malaria. Lancet 1964; 1: 240-241
    PubMedGoogle Scholar
  • 3 Fajardo LF. The role of platelet in infections – 1: Observations in human and murine malaria. Arch Pathol Lab Med 1979; 103-134
    PubMedGoogle Scholar
  • 4 Essien EM, Oruamabo RS. Depression of platelet count during acute falciparum malaria infection. Niger J Paed 1976; 3: 69-70
    PubMedGoogle Scholar
  • 5 Essien EM, Adekunle CO, Ebhota M, Oruamabo RS. Effect of acute plasmodium falciparum infection on platelet count in man. Niger J Med Sei 1979; 1: 59-63
    PubMedGoogle Scholar
  • 6 Skudowitz ES, Matz J, Nurie A, Levin J, Metz J. Mechanisms of thrombocytopaenia in malignant tertian malaria. Brit med J 1973; 2: 515-517
    CrossrefPubMedGoogle Scholar
  • 7 Borochovitz D, Crosley AL, Metz J. Disseminated intravascular coagulation in plasmodium falciparum malaria. Brit Med J 1970; 2: 170
    PubMedGoogle Scholar
  • 8 Beale PF, Cormack JD, Oldrey TB N. Thrombocytopaenia in malaria with immunoglobulin (IgM) changes. Brit Med J 1972; 1: 345-349
    CrossrefPubMedGoogle Scholar
  • 9 Srichaikul T, Puwasatin P, Karnjanajetanee J, Bokisch VA. Complement changes & disseminated intravascular coagulation in plasmodium falciparum malaria. Lancet 1975; 1: 770-772
    PubMedGoogle Scholar
  • 10 Essien EM, Ebhota MI. Mild depression of platelet count and altered platelet function in acute plasmodium falciparum infection. Thromb Haemostas 1977; 38: 93
    PubMedGoogle Scholar
  • 11 B-Thromboglobulin (B-TG) RIA kit procedure pamphlet. Amersham: 1977
  • 12 Born GV R. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927-929
    PubMedGoogle Scholar
  • 13 O’Brien JF. Platelet aggregation. I. Some effects of the adenosine phosphates, thrombin and cocaine upon platelet adhesiveness. J Clin Pathol 1962; 15: 446-452
    CrossrefPubMedGoogle Scholar
  • 14 Mustard JF, Hagardt S, Rowsell HC, MacMillan RL. Effect of adenosine nucleotides on platelet aggregation and clotting time. J Lab Clin Med 1964; 64: 548-559
    PubMedGoogle Scholar
  • 15 Ludlam CA, Moore S, Bolton AE, Pepper DS, Cash JD. The release of a human platelet-specific protein measured by radioimmunoassay. Thromb Res 1975; 6: 543-548
    CrossrefPubMedGoogle Scholar
  • 16 Packham MA, Kinlough-Rathbone RL, Mustard JF. Aggregation and agglutination. In: Day HJ, Holmsen H, Zucker MB. (eds.) Platelet Function Testing DHEW Publication No.(NIH) 78-1087, U.S. Department of Health, Education & Welfare 1978; 66-90
    PubMedGoogle Scholar
  • 17 Breddin K, Krzywanek JH, Bald M, Kutschera J. Platelet aggregation control: clinical potential. Is enhanced platelet aggregation a risk factor for thromboembolic complications in atherosclerosis In: Caprino L, Rossi EC. (eds.) Platelet aggregation and Drugs. Academic Press; p 197 London: 1974
    Google Scholar
  • 18 Rathbone RO, Ardlie NG, Schwartz CJ. Platelet aggregation and thrombus formation in diabetes mellitus: an in vitro study. Pathology 1970; 2: 307-318
    CrossrefPubMedGoogle Scholar
  • 19 Steinberg D, Carvalho AC, Chesney CM, Colman RW. Platelet hypersensitivity and intravascular coagulation in paroxysmal nocturnal hemoglobinuria. Am J Med 1975; 59: 845-850
    CrossrefPubMedGoogle Scholar
  • 20 Lentini S, Bologne E. Hypertension and platelet aggregation. In: Caprino L, Rossi EC. (eds.) Platelet Aggregation and Drugs. p 63 Academic Press; New York: 1974
    Google Scholar
  • 21 Packham MA. Methods for detection of hypersensitive platelets. Thromb Haemostas 1978; 400: 175-195
    PubMedGoogle Scholar
  • 22 Breddin K, Grun H, Krzywanek HJ, Schremmer WP. On the measurement of spontaneous platelet aggregation. The platelet aggre-gation test III. Method and first clinical results Thromb Haemostas 1976; 35: 669-691
    PubMedGoogle Scholar